These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 20092246)
1. Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast. Lim KH; Telisinghe PU; Abdullah MS; Ramasamy R Cancer Immun; 2010 Jan; 10():3. PubMed ID: 20092246 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Yakirevich E; Izhak OB; Rennert G; Kovacs ZG; Resnick MB Mod Pathol; 1999 Nov; 12(11):1050-6. PubMed ID: 10574602 [TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Tamiolakis D; Simopoulos C; Cheva A; Lambropoulou M; Kotini A; Jivannakis T; Papadopoulos N Eur J Gynaecol Oncol; 2002; 23(5):433-6. PubMed ID: 12440819 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma. Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657 [TBL] [Abstract][Full Text] [Related]
5. Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast. Xu R; Feiner H; Li P; Yee H; Inghirami G; Delgado Y; Perle MA Arch Pathol Lab Med; 2003 Nov; 127(11):1458-64. PubMed ID: 14567723 [TBL] [Abstract][Full Text] [Related]
6. CD8+ lymphocytes and apoptosis in typical and atypical medullary carcinomas of the breast. Nurlaila I; Telisinghe PU; Ramasamy R Immunol Lett; 2013; 156(1-2):123-6. PubMed ID: 24120509 [TBL] [Abstract][Full Text] [Related]
7. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Kuroda H; Tamaru J; Sakamoto G; Ohnisi K; Itoyama S Virchows Arch; 2005 Jan; 446(1):10-4. PubMed ID: 15660281 [TBL] [Abstract][Full Text] [Related]
8. Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast. Guo X; Fan Y; Lang R; Gu F; Chen L; Cui L; Pringle GA; Zhang X; Fu L Mod Pathol; 2008 Sep; 21(9):1101-7. PubMed ID: 18469794 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast. Yakirevich E; Maroun L; Cohen O; Izhak OB; Rennert G; Resnick MB J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Mahmoud SM; Lee AH; Paish EC; Macmillan RD; Ellis IO; Green AR Breast Cancer Res Treat; 2012 Apr; 132(2):545-53. PubMed ID: 21671016 [TBL] [Abstract][Full Text] [Related]
11. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype. Anz D; Eiber S; Scholz C; Endres S; Kirchner T; Bourquin C; Mayr D Histopathology; 2011 Nov; 59(5):965-74. PubMed ID: 22092408 [TBL] [Abstract][Full Text] [Related]
12. Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype. Orlando L; Renne G; Rocca A; Curigliano G; Colleoni M; Severi G; Peruzzotti G; Cinieri S; Viale G; Sanna G; Goldhirsch A Ann Oncol; 2005 Jul; 16(7):1094-9. PubMed ID: 15855225 [TBL] [Abstract][Full Text] [Related]
13. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ. Miligy I; Mohan P; Gaber A; Aleskandarany MA; Nolan CC; Diez-Rodriguez M; Mukherjee A; Chapman C; Ellis IO; Green AR; Rakha EA Histopathology; 2017 Aug; 71(2):258-268. PubMed ID: 28326600 [TBL] [Abstract][Full Text] [Related]
15. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status. Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; OkoĊ K Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433 [TBL] [Abstract][Full Text] [Related]
16. Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer. Verma R; Hanby AM; Horgan K; Verghese ET; Volpato M; Carter CR; Hughes TA Breast Cancer Res Treat; 2020 Aug; 183(1):49-59. PubMed ID: 32577938 [TBL] [Abstract][Full Text] [Related]
17. Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ. Beguinot M; Dauplat MM; Kwiatkowski F; Lebouedec G; Tixier L; Pomel C; Penault-Llorca F; Radosevic-Robin N BMC Cancer; 2018 Feb; 18(1):129. PubMed ID: 29394917 [TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast. Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A BMC Cancer; 2021 Mar; 21(1):286. PubMed ID: 33726701 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables. Helal TE; Ibrahim EA; Alloub AI Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance. Althobiti M; Aleskandarany MA; Joseph C; Toss M; Mongan N; Diez-Rodriguez M; Nolan CC; Ashankyty I; Ellis IO; Green AR; Rakha EA Histopathology; 2018 Dec; 73(6):887-896. PubMed ID: 29947077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]